{"id":"NCT00714688","sponsor":"Janssen-Cilag International NV","briefTitle":"A Study to Evaluate Effectiveness and Safety of Prolonged Release OROS Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder","officialTitle":"A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Response Study to Evaluate Efficacy and Safety of Prolonged Release (PR) OROS Methylphenidate (54 and 72 mg/Day) in Adults With Attention Deficit/Hyperactivity Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-02","primaryCompletion":"2009-04","completion":"2009-04","firstPosted":"2008-07-14","resultsPosted":"2010-04-21","lastUpdate":"2014-05-08"},"enrollment":279,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Attention Deficit/ Hyperactivity Disorder"],"interventions":[{"type":"DRUG","name":"prolonged release (PR) OROS methylphenidate 54 mg","otherNames":[]},{"type":"DRUG","name":"prolonged release (PR) OROS methylphenidate 72 mg","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"001","type":"EXPERIMENTAL"},{"label":"002","type":"EXPERIMENTAL"},{"label":"003","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy of 2 fixed dosages of Prolonged Release (PR) OROS methylphenidate (54 and 72 mg/day) compared with placebo in adult patients with attention deficit/hyperactivity disorder (ADHD).","primaryOutcome":{"measure":"Attention Deficit/Hyperactivity Disorder (ADHD) Symptoms Total Score of the Conners Adult ADHD Rating Scale (CAARS)","timeFrame":"from baseline to 13 weeks","effectByArm":[{"arm":"Placebo","deltaMin":36.5,"sd":6.05},{"arm":"54 mg PR OROS MPH","deltaMin":35.6,"sd":6.75},{"arm":"72 mg PR OROS MPH","deltaMin":37.3,"sd":6.35}],"pValues":[{"comp":"OG000 vs OG001","p":"0.136"},{"comp":"OG000 vs OG002","p":"0.002"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":42,"countries":["Belgium","Denmark","Finland","France","Germany","Netherlands","Norway","Spain","Sweden","Switzerland","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":97},"commonTop":["Headache","Decreased Appetite","Insomnia","Nausea","Nasopharyngitis"]}}